gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with Extravasation of Contrast Media in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Daelemans, R; Gheuens, E; Mesens, S | 1 |
| Berger, F; Lahrech, H; Nissou, MF; Perles-Barbacaru, AT; Sarraf, M; van der Sanden, B | 1 |
| Allegrini, PR; Drevs, J; Esser, N; Fuxius, S; Hennig, J; Hugenschmidt, H; Konerding, MA; Marmé, D; Müller-Driver, R; Unger, C; Wittig, C; Wood, J | 1 |
| Kramann, B; Schneider, G; Seidel, R; Uder, M; Wagner, D; Weinmann, HJ | 1 |
1 trial(s) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Extravasation of Contrast Media
| Article | Year |
|---|---|
Dialysability of gadoteric acid in patients with end-stage renal disease undergoing hemodialysis.
Topics: Adult; Aged; Biological Availability; Contrast Media; Extravasation of Diagnostic and Therapeutic Materials; Female; Heterocyclic Compounds; Humans; Kidney; Kidney Failure, Chronic; Male; Metabolic Clearance Rate; Middle Aged; Organometallic Compounds; Patient Safety; Renal Dialysis; Reproducibility of Results; Sensitivity and Specificity | 2014 |
3 other study(ies) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Extravasation of Contrast Media
| Article | Year |
|---|---|
Rapid-Steady-State-T1 signal modeling during contrast agent extravasation: toward tumor blood volume quantification without requiring the arterial input function.
Topics: Animals; Blood Volume; Blood Volume Determination; Brain Neoplasms; Cell Line, Tumor; Computer Simulation; Contrast Media; Extravasation of Diagnostic and Therapeutic Materials; Heterocyclic Compounds; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Models, Biological; Neovascularization, Pathologic; Organometallic Compounds; Rats; Rats, Inbred F344 | 2015 |
PTK787/ZK 222584, a specific vascular endothelial growth factor-receptor tyrosine kinase inhibitor, affects the anatomy of the tumor vascular bed and the functional vascular properties as detected by dynamic enhanced magnetic resonance imaging.
Topics: Angiogenesis Inhibitors; Animals; Benzimidazoles; Blood Vessels; Capillary Permeability; Carcinoma, Renal Cell; Enzyme Inhibitors; Extravasation of Diagnostic and Therapeutic Materials; Female; Fluorescent Dyes; Heterocyclic Compounds; Kidney Neoplasms; Magnetic Resonance Angiography; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Organometallic Compounds; Phthalazines; Pyridines; Receptor Protein-Tyrosine Kinases; Receptors, Growth Factor; Receptors, Vascular Endothelial Growth Factor; Regional Blood Flow | 2002 |
In vivo microscopic evaluation of the microvascular behavior of FITC-labeled macromolecular MR contrast agents in the hamster skinfold chamber.
Topics: Animals; Capillary Permeability; Contrast Media; Cricetinae; Extravasation of Diagnostic and Therapeutic Materials; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Magnetic Resonance Imaging; Male; Melanoma, Amelanotic; Melanoma, Experimental; Microcirculation; Microscopy, Fluorescence; Organometallic Compounds; Random Allocation; Skin Neoplasms; Time Factors; Video Recording | 2000 |